Latest Blog Posts Tagged "Research News"
January 12, 2018
Michael J. Fox Foundation-funded researchers have created exquisitely sensitive antibodies that may help test therapies against a top Parkinson's drug target.
January 04, 2018
A recent study shows that the way people with Parkinson's process caffeine could help identify disease earlier.
December 22, 2017
Missed our Year in Review webinar? Catch up with this recording and hear our panelists recap new potential Parkinson's treatments in clinical testing.
December 21, 2017
Denali Therapeutics announced its first-in-human LRRK2 inhibitor is safe and lowers LRRK2 protein activity in humans' body cells, meaningful milestones for this potentially disease-modifying therapy.
December 18, 2017
A new phase II study adds to the growing body of evidence on the effects of exercise for people with Parkinson's.